Literature DB >> 21722093

Dopamine and vascular dynamics control: present status and future perspectives.

Seyed Khosrow Tayebati1, Mustafa F Lokhandwala, Francesco Amenta.   

Abstract

The catecholamine dopamine is a precursors in the biosynthesis of norepinephrine and epinephrine as well as a neurotransmitter in the central nervous system. Besides of its well known role of brain neurotransmitter, dopamine exerts specific functions at the periphery, being those at the level of the cardiovascular system and the kidney the most relevant. In fact it plays a role of modulator of blood pressure, sodium balance, and renal and adrenal functions through an independent peripheral dopaminergic system. In vivo administration or in vitro application of dopamine or of dopamine receptor agonists induce vasodilatation in the cerebral, coronary, renal and mesenteric vascular beds and cause hypotension. Moreover, dopamine stimulates cardiac contractility and induces diuresis and natriuresis. Dopamine probably plays a role in the pathogenesis of arterial hypertension by regulating epithelial sodium transport, vascular smooth muscle contractility and production of reactive oxygen species and by interacting with the renin-angiotensin and sympathetic nervous systems. Dopamine exerts its actions via a class of cell surface receptors belonging to the rhodopsin-like family of G-protein coupled receptors. Dopamine receptors are classified into D1-like (D1 and D5) and D2-like (D2, D3 and D4) subtypes based on their structure and pharmacology. Each of the dopamine receptor subtypes can participate in the regulation of blood pressure by specific mechanisms. Some receptors regulate blood pressure by influencing the central and/or autonomic nervous system; others influence epithelial transport and regulate the secretion and receptors of several humeral agents. This paper outlines the biochemistry, anatomical localization and physiology of the different dopamine receptors involved in the regulation of blood pressure, the relationship between dopamine receptor subtypes and hypertension and possibilities of modulating pharmacologically vascular dopamine receptor function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722093     DOI: 10.2174/156720211796558032

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  24 in total

1.  Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells.

Authors:  Debanjan Chakroborty; Chandrani Sarkar; Hongmei Yu; Jiang Wang; Zhongfa Liu; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.

Authors:  Yongqiao Zhou; Weibin Shi; Hao Luo; Rongchuan Yue; Zhen Wang; Wei Wang; Li Liu; Wei Eric Wang; Hongyong Wang; Chunyu Zeng
Journal:  Hypertens Res       Date:  2015-07-16       Impact factor: 3.872

3.  Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells.

Authors:  Shaoxiong Wang; Xi Lu; Jian Yang; Hongyong Wang; CaiYu Chen; Yu Han; Hongmei Ren; Shuo Zheng; Duofen He; Lin Zhou; Laureano D Asico; Wei Eric Wang; Pedro A Jose; Chunyu Zeng
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-05

4.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

5.  Dopamine D₁-like receptors regulate the α₁A-adrenergic receptor in human renal proximal tubule cells and D₁-like dopamine receptor knockout mice.

Authors:  Riley Charles Ennis; Laureano D Asico; Ines Armando; Jian Yang; Jun B Feranil; Julie A Jurgens; Crisanto S Escano; Peiying Yu; Xiaoyan Wang; David R Sibley; Pedro A Jose; Van Anthony M Villar
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-22

6.  Altered Coupling Between Resting-State Cerebral Blood Flow and Functional Connectivity in Schizophrenia.

Authors:  Jiajia Zhu; Chuanjun Zhuo; Lixue Xu; Feng Liu; Wen Qin; Chunshui Yu
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

Review 7.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

Review 8.  Dopaminergic Regulation of Innate Immunity: a Review.

Authors:  Monica Pinoli; Franca Marino; Marco Cosentino
Journal:  J Neuroimmune Pharmacol       Date:  2017-06-03       Impact factor: 4.147

9.  Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells.

Authors:  Shengzhi Liu; Yao Fan; Andy Chen; Aydin Jalali; Kazumasa Minami; Kazuhiko Ogawa; Harikrishna Nakshatri; Bai-Yan Li; Hiroki Yokota
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

10.  Cytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-D-aspartate receptor coupling.

Authors:  Neelima P Sidharthan; Rodney F Minchin; Neville J Butcher
Journal:  J Biol Chem       Date:  2013-10-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.